Fields of Study

• Breast Radiology, Breast Interventions
• Oncologic PET / MRI imaging
• Non-vascular interventions

Career Summary

• Istanbul University School of Medicine, 1997-2003
• Gazi University School of Medicine Department of Radiology, 2004-2010
• University of Pennslyvania ve Children’s Hospital of Philadelphia (CHOP), 2009
• Elazığ Training and Research Hospital Department of Radiology, 2010-2012
• Gayrettepe Florence Nightingale Hospital Department of Radiology, 2012-2019
• Demiroğlu Bilim University Department of Radiology, 2015-2016
• Yeditepe University School of Medicine Department of Radiology, 2019 -  )

Memberships

• Turkish Society of Radiology
• Turkish Society of Magnetic Resonance Imaging
• Radiological Society of North America
• European Society of Radiology
• European Society of Breast Imaging

Publıcatıons

1. Evaluation of Anti-Mullerian Hormone Levels, Antral Follicle Counts, and Mean Ovarian Volumes in Chemotherapy-Induced Amenorrhea among Breast Cancer Patients: A Prospective Clinical Study.
Ünal Ç, Ordu Ç, Özmen T, İlgun AS, Çelebi F, Baysal B, Özkurt E, Duymaz T, Erdoğan İyigün Z, Kurt S, Öztürk MA, Pilancı KN, Alço G, Yararbaş K, Kayan Tapan T, Güven DC, Soybir G, Özmen V.Curr Oncol. 2023 Oct 19;30(10):9217-9229. doi: 10.3390/curroncol30100666.

2. MCM-2 Levels as a Potential Biomarker for Predicting High-Risk Breast Cancer Patients According to TAILORx Classification.
Ünal Ç, Özmen T, İlgün AS, Ordu Ç, Özkurt E, Ak N, Alço G, Erdoğan İyigün Z, Kurt S, Duymaz T, Öztürk MA, Elbüken Çelebi F, Yararbaş K, Soybir G, Aktepe F, Özmen V.Breast Cancer (Dove Med Press). 2023 Sep 1;15:659-669. doi: 10.2147/BCTT.S421535. eCollection 2023.

3. Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey.
Ünal Ç, Özmen T, Ordu Ç, Pilanci KN, İlgün AS, Gökmen E, Almuradova E, Özdoğan M, Güler N, Uras C, Kara H, Demircan O, Işık S, Alço G, Saip P, Aydın E, Duymaz T, Çelebi F, Yararbaş K, Soybir G, Ozmen V.Front Oncol. 2023 Jun 28;13:1151733. doi: 10.3389/fonc.2023.1151733. eCollection 2023.

4. The effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes in patients with breast cancer.
Ilgun AS, Aktepe F, Gonullu O, Kapucuoglu N, Yararbas K, Alco G, Ozturk A, Elbuken Celebi F, Erdogan Z, Ordu C, Unal C, Duymaz T, Soybir G, Yavuz E, Tuzlali S, Ozmen V.Future Oncol. 2022 Sep;18(29):3289-3298. doi: 10.2217/fon-2022-0157. Epub 2022 Aug 26.

5. The value of 18F-FDG PET/MRI in prediction of microvascular invasion in hepatocellular carcinoma.
Çelebi F, Görmez A, Ilgun AS, Tokat Y, Balcı NC.Eur J Radiol. 2022 Apr;149:110196. doi: 10.1016/j.ejrad.2022.110196. Epub 2022 Feb 4.

6. Prediction of IDH Mutation Status in High-grade Gliomas Using DWI and High T1-weight DSC-MRI.
Cindil E, Sendur HN, Cerit MN, Erdogan N, Celebi F, Dag N, Celtikci E, Inan A, Oner Y, Tali T.Acad Radiol. 2022 Mar;29 Suppl 3:S52-S62. doi: 10.1016/j.acra.2021.02.002. Epub 2021 Mar 6.

7. Validation of combined use of DWI and percentage signal recovery-optimized protocol of DSC-MRI in differentiation of high-grade glioma, metastasis, and lymphoma.
Cindil E, Sendur HN, Cerit MN, Dag N, Erdogan N, Celebi FE, Oner Y, Tali T.Neuroradiology. 2021 Mar;63(3):331-342. doi: 10.1007/s00234-020-02522-9. Epub 2020 Aug 21.

8. The Effect of Systemic Chemotherapy on Ovarian Function: A Prospective Clinical Trial.
Çelebi F, Ordu Ç, Ilgün S, Oztürk A, Erdoğan Iyigün Z, Alço G, Duymaz T, Aktepe F, Soybir G, Baysal B, Özmen V.Eur J Breast Health. 2020 Mar 17;16(3):177-182. doi: 10.5152/ejbh.2020.5114. eCollection 2020 Jul.

9. The Role of 18F-FDG PET/MRI in the Assessment of Primary Intrahepatic Neoplasms.
Çelebi F, Yaghouti K, Cindil E, Dogusoy GB, Tokat Y, Balcı C. Acad Radiol2021 Feb;28(2):189-198.doi: 10.1016/j.acra.2020.01.026. Epub 2020 Feb 25.
10. Usefulness of imaging findings in predicting tumor-infiltrating lymphocytes in patients with breast cancer.
Çelebi F, Agacayak F, Ozturk A, Ilgun S, Ucuncu M, Iyigun ZE, Ordu Ç, Pilanci KN, Alco G, Gultekin S, Cindil E, Soybir G, Aktepe F, Özmen V.Eur Radiol. 2020 Apr;30(4):2049-2057. doi: 10.1007/s00330-019-06516-x. Epub 2019 Dec 10.

11. LONG-TERM SURVIVAL EFFECTS OF PREOPERATIVE BREAST MRI IN PATIENTS WITH BREAST-CONSERVING SURGERY.
Ilgun AS, Sarsenov D, Alco G, Ozturk A, Agacayak F, Elbuken F, Erdogan Z, Pilanci KN, Ordu C, Aktepe F, Soybir G, Ozmen V.Acta Clin Croat. 2022 Mar;61(1):30-37. doi: 10.20471/acc.2022.61.01.04.

12. The effect of multifocal and multicentric tumours on local recurrence and survival outcomes in breast cancer.
Ozturk A, Ilgun S, Ucuncu M, Gachayev F, Ordu C, Alco G, Elbuken F, Erdogan Z, Duymaz T, Aktepe F, Soybir G, Ozmen V.J BUON. 2021 Jan-Feb;26(1):196-203.

13. Pre-Treatment and Post-Treatment Anxiety, Depression, Sleep and Sexual Function Levels in Patients with Breast Cancer.
İzci F, Özdem G, İlgün AS, Ağaçayak F, Duymaz T, Erdoğan Z, Alço G, Elbüken F, Öztürk A, Ordu Ç, Ateşal KC, Doğan Öİ, Aktepe F, Özmen V.Eur J Breast Health. 2020 Apr 17;16(3):219-225. doi: 10.5152/ejbh.2020.5259. eCollection 2020 Jul.

14. Comparison of breast cancer patients who underwent partial mastectomy (PM) with mini latissimus dorsi flap (MLDF) and subcutaneous mastectomy with implant (M + I) regarding quality of life (QOL), cosmetic outcome and survival rates.
Ozmen V, Ilgun S, Celet Ozden B, Ozturk A, Aktepe F, Agacayak F, Elbuken F, Alco G, Ordu C, Erdogan Iyigun Z, Emre H, Pilancı K, Soybir G, Ozmen T.World J Surg Oncol. 2020 May 5;18(1):87. doi: 10.1186/s12957-020-01858-z.

15.  Added Value of Contrast Medium in Whole-Body Hybrid Positron Emission Tomography/Magnetic Resonance Imaging: Comparison between Contrast-Enhanced and Non-Contrast-Enhanced Protocols.
Celebi F, Cindil E, Sarsenov D, Unalan B, Balcı C.Med Princ Pract. 2020;29(1):54-60. doi: 10.1159/000501497. Epub 2019 Jun 17.

16. What is the Diagnostic Performance of 18F-FDG-PET/MRI in the Detection of Bone Metastasis in Patients with Breast Cancer?
Çelebi F.Eur J Breast Health. 2019 Oct 1;15(4):213-216. doi: 10.5152/ejbh.2019.4885. eCollection 2019 Oct.

17. The Relationship between Bone Mineral Density and Estrogen Receptor Positivity in Patients with Breast Cancer.
İyigün ZE, Pilancı KN, Çabuk FK, İlgün S, Ordu Ç, Duymaz T, Alço G, Çelebi F, Sarsenov D, İzci F, Öztürk A, Ağaçayak F, Köksal Üİ, Aktepe F, Eralp Y, Özmen V.J Breast Health. 2016 Jul 1;12(3):119-122. doi: 10.5152/tjbh.2016.2961. eCollection 2016 Jul.

18. The Role of Elastography in Diagnosis and Staging of Breast Cancer-Related Lymphedema.
Erdogan Iyigun Z, Agacayak F, Ilgun AS, Elbuken Celebi F, Ordu C, Alco G, Ozturk A, Duymaz T, Aktepe F, Ozmen V.Lymphat Res Biol. 2019 Jun;17(3):334-339. doi: 10.1089/lrb.2018.0012. Epub 2018 Sep 13.

19. Synchronous and metachronous bilateral breast cancer: A long-term experience.
Ozturk A, Alco G, Sarsenov D, Ilgun S, Ordu C, Koksal U, Nur Pilanci K, Erdogan Z, Izci F, Elbuken F, Agacayak F, Aktepe F, Ozmen V.J BUON. 2018 Nov-Dec;23(6):1591-1600.

20. Preoperative Lymphedema-Related Risk Factors in Early-Stage Breast Cancer.
Iyigun ZE, Duymaz T, Ilgun AS, Alco G, Ordu C, Sarsenov D, Aydin AE, Celebi FE, Izci F, Eralp Y, Ozmen V.Lymphat Res Biol. 2018 Feb;16(1):28-35. doi: 10.1089/lrb.2016.0045. Epub 2017 Mar 27.

21. Prognostic Significance of Adjuvant Chemotherapy Induced Amenorrhea in Luminal A and B Subtypes.
Ordu Ç, Pilancı KN, Alço G, Elbüken F, Köksal Üİ, İlgun S, Sarsenov D, Aydın AE, Öztürk A, Erdoğan Zİ, Ağaçayak F, Çubuk F, Tecimer C, Eralp Y, Duymaz T, Aktepe F, Özmen V.Eur J Breast Health. 2018 Jul 1;14(3):173-179. doi: 10.5152/ejbh.2018.3808. eCollection 2018 Jul.

22. Impact of Personality Traits, Anxiety, Depression and Hopelessness Levels on Quality of Life in the Patients with Breast Cancer.
İzci F, Sarsanov D, Erdogan Zİ, İlgün AS, Çelebi E, Alço G, Kocaman N, Ordu Ç, Öztürk A, Duymaz T, Pilavcı KN, Elbüken F, Ağaçayak F, Aktepe F, Ünveren G, Özdem G, Eralp Y, Özmen V.Eur J Breast Health. 2018 Apr 1;14(2):105-111. doi: 10.5152/ejbh.2018.3724. eCollection 2018 Apr.

23. The Effect of Mini-Latissimus Dorsi Flap (MLDF) Reconstruction on Shoulder Function in Breast Cancer Patients.
Duymaz T, İyigün ZE, İlgün AS, Ordu Ç, Üçüncü M, Alço G, Öztürk A, Elbüken F, Aktepe F, Özmen V.Eur J Breast Health. 2019 Jul 1;15(3):158-162. doi: 10.5152/ejbh.2019.4727. eCollection 2019 Jul.

24. Compatibility of Lauge-Hansen Classification Between Plain Radiographs and Magnetic Resonance Imaging in Ankle Fractures.
Çabuk H, Çelebi F, İmren Y, Dedeoğlu SS, Kır MÇ, Uyanık AF, Gürbüz H.J Foot Ankle Surg. 2018 Jul-Aug;57(4):712-715. doi: 10.1053/j.jfas.2017.12.009. Epub 2018 Apr 19.

25. Receptor discordance rate and its effects on survival in primary and recurrent breast cancer patients.
Ilgun S, Sarsenov D, Erdogan Z, Ordu C, Celebi F, Nur Pilanci K, Ozturk A, Selamoglu D, Alco G, Aktepe F, Eralp Y, Tuzlali S, Ozmen V.J BUON. 2016 Nov-Dec;21(6):1425-1432.

26. Replacement of the tumor bed following oncoplastic breast-conserving surgery with immediate latissimus dorsi mini-flap.
Alço G, Igdem S, Okkan S, Dincer M, Sarsenov D, Ilgun AS, Agacayak F, Elbüken F, Ercan T, Selamoglu D, Ozmen V.Mol Clin Oncol. 2016 Oct;5(4):365-371. doi: 10.3892/mco.2016.984. Epub 2016 Aug 9.

27. The Prognostic Impact of Molecular Subtypes and Very Young Age on Breast Conserving Surgery in Early Stage Breast Cancer.
Ordu C, McGuire K, Alco G, Nur Pilanci K, Koksal UI, Elbüken F, Erdogan Z, Agacayak F, Ilgun S, Sarsenov D, Öztürk A, İğdem Ş, Okkan S, Eralp Y, Dincer M, Ozmen V.Cureus. 2016 Jun 7;8(6):e633. doi: 10.7759/cureus.633.

28. Prognostic relevance of sunitinib toxicities and comparison of continuous vs. intermittent sunitinib dosing schedule in metastatic renal cell cancer patients.
Ordu Ç, Pilanci KN, Avcı N, Yıldız İ, Alço G, Demirhan Ö, Köksal ÜI, Elbüken F, Tecimer C, Demir G.Contemp Oncol (Pozn). 2016;20(2):147-52. doi: 10.5114/wo.2016.60069. Epub 2016 Jun 14.

30. True Local Recurrences after Breast Conserving Surgery have Poor Prognosis in Patients with Early Breast Cancer.
Sarsenov D, Ilgun S, Ordu C, Alco G, Bozdogan A, Elbuken F, Nur Pilanci K, Agacayak F, Erdogan Z, Eralp Y, Dincer M, Ozmen V.Cureus. 2016 Mar 24;8(3):e541. doi: 10.7759/cureus.541.

31. A Rare Tumor that Mimicked Metastasis in a Patient with Breast Cancer: Epithelioid Hemangioendothelioma.
Çabuk FK, Aktepe F, İlgün AS, Sarsenov D, Elbüken F, Özmen V.J Breast Health. 2016 Apr 1;12(2):83-85. doi: 10.5152/tjbh.2016.2844. eCollection 2016 Apr.

32. Bioelectrical impedance for detecting and monitoring lymphedema in patients with breast cancer. Preliminary results of the florence nightingale breast study group.
Erdogan Iyigun Z, Selamoglu D, Alco G, Pilancı KN, Ordu C, Agacayak F, Elbüken F, Bozdogan A, Ilgun S, Guler Uysal F, Ozmen V.Lymphat Res Biol. 2015 Mar;13(1):40-5. doi: 10.1089/lrb.2014.0014. Epub 2014 Dec 19.

33. A Rare Case of Sunitinib-Induced Hyperammonemic Encephalopathy and Hypothyroidism in Metastatic Renal Cell Carcinoma.
Pilanc KN, Elbüken F, Ordu Ç, Köksal G, Tekelioğlu MH, Okutur K, Göksel S, Köksal Ü, Akçal T, Tecimer C.Am J Ther. 2016 Mar-Apr;23(2):e583-7. doi: 10.1097/MJT.0b013e3182a32e0e.

34. Dramatic Response to Catumaxomab Treatment for Malign Ascites Related to Renal Cell Carcinoma With Sarcomotoid Differentiation.
Pilanc KN, Ordu Ç, Akpnar H, Balc C, Başsülü N, Köksal Üİ, Elbüken F, Okutur K, Bülbül G, Sağlam S, Demir G.Am J Ther. 2016 Jul-Aug;23(4):e1078-81. doi: 10.1097/MJT.0000000000000064.

35. The Effect of Mini-Latissimus Dorsi Flap (MLDF) Reconstruction on Shoulder Function in Breast Cancer Patients.
Duymaz T, İyigün ZE, İlgün AS, Ordu Ç, Üçüncü M, Alço G, Öztürk A, Elbüken F, Aktepe F, Özmen V.Eur J Breast Health. 2019 Jul 1;15(3):158-162. doi: 10.5152/ejbh.2019.4727. eCollection 2019 Jul.PMID: 31312791.

36. The Relationship between Bone Mineral Density and Estrogen Receptor Positivity in Patients with Breast Cancer.
İyigün ZE, Pilancı KN, Çabuk FK, İlgün S, Ordu Ç, Duymaz T, Alço G, Çelebi F, Sarsenov D, İzci F, Öztürk A, Ağaçayak F, Köksal Üİ, Aktepe F, Eralp Y, Özmen V.J Breast Health. 2016 Jul 1;12(3):119-122. doi: 10.5152/tjbh.2016.2961. eCollection 2016 Jul.PMID: 28331747.

37. PET-MRI Findings of Two Patients with Breast Carcinoma before Treatment.
Çelebi F, Köksal Ü, Pilancı KN, Ordu Ç, Sarsenov D, İlgün S, Çabuk FK, Alço G, Özdil G, Erdoğan Z, Özmen V.J Breast Health. 2016 Apr 1;12(2):88-90. doi: 10.5152/tjbh.2016.2867. eCollection 2016 Apr.PMID: 28331741.

38. Primary renal angiosarcoma with progressive clinical course despite surgical and adjuvant treatment: A case report. 
Celebi F, Pilanci KN, Saglam S, Balci NC.Oncol Lett. 2015 Apr;9(4):1937-1939. doi: 10.3892/ol.2015.2902. Epub 2015 Jan 27.PMID: 25789072 Free PMC article.  

39. Macrodystrophia lipomatosa of the foot: A case report. 
Çelebi F, Karagulle K, Oner AY.Oncol Lett. 2015 Aug;10(2):951-953. doi: 10.3892/ol.2015.3300. Epub 2015 Jun 2. PMID: 26622602.

40. The role of ultrasonographic findings to predict molecular subtype, histologic grade, and hormone receptor status of breast cancer. 
Çelebi F, Pilancı KN, Ordu Ç, Ağacayak F, Alço G, İlgün S, Sarsenov D, Erdoğan Z, Özmen V.Diagn Interv Radiol. 2015 Nov-Dec;21(6):448-53. doi: 10.5152/dir.2015.14515.PMID: 26359880 .

41. Is administration of trastuzumab an independent risk factor for developing osteonecrosis of the jaw among metastatic breast cancer patients under zoledronic acid treatment?
Pilanci KN, Alco G, Ordu C, Sarsenov D, Celebi F, Erdogan Z, Agacayak F, Ilgun S, Tecimer C, Demir G, Eralp Y, Okkan S, Ozmen V.Medicine (Baltimore). 2015 May;94(18):e671. doi: 10.1097/MD.0000000000000671.PMID: 25950681.

42. The relationship between bone mineral density and arterial stiffness in women.
Baykara M, Öztürk C, Elbüken F.Diagn Interv Radiol. 2012 Sep-Oct;18(5):441-5. doi: 10.4261/1305-3825.DIR.5330-11.1. Epub 2012 Mar 20

43. Standardisation of the neck-shaft angle and measurement of age-, gender- and BMI-related changes in the femoral neck using DXA.
Elbuken F, Baykara M, Ozturk C.Singapore Med J. 2012 Sep;53(9):587-90.